In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
Authors
Keywords
Hyporesponsiveness, Erythropoiesis-stimulating agents, Prediction, Claims database
Journal
BMC Nephrology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-14
DOI
10.1186/s12882-019-1554-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study
- (2016) Ylenia Ingrasciotta et al. PLoS One
- ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage
- (2016) Takahiro Kuragano et al. PLoS One
- How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009–2013
- (2015) Ylenia Ingrasciotta et al. BIODRUGS
- Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients
- (2015) Scott P. Sibbel et al. BMC Nephrology
- Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
- (2013) David T Gilbertson et al. BMC Nephrology
- Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
- (2013) Marit M Suttorp et al. BMC Nephrology
- Factors Predicting Erythropoietin Resistance among Maintenance Hemodialysis Patients
- (2012) Salman Mallick et al. BLOOD PURIFICATION
- Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
- (2012) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
- (2010) Eliyahu V. Khankin et al. PLoS One
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
- (2009) Kamyar Kalantar-Zadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality
- (2008) Juan M. López-Gómez et al. KIDNEY INTERNATIONAL
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Hemoglobin Level Variability: Associations with Mortality
- (2007) D. T. Gilbertson et al. Clinical Journal of the American Society of Nephrology
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started